Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4310 is a human microRNA gene that encodes a short, non-coding RNA involved in the post-transcriptional regulation of gene expression[6]. Like other microRNAs, MIR4310 functions by base-pairing with target messenger RNAs (mRNAs), leading to translational inhibition or mRNA degradation, thereby modulating downstream protein levels[1][6]. Recent studies suggest that MIR4310 may act as a tumor suppressor in colorectal cancer, and it has potential as a biomarker for early cancer screening[4]. However, the broader biological functions and disease associations of MIR4310 remain only partially characterized and require further research. As of now, it is not a direct target for any approved or investigational therapeutic agents.
N/A for drugs. For endogenous function, microRNA 4310 binds to complementary sequences in target mRNAs, inhibiting their translation or promoting degradation[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4310 (MIR4310).